Qin C, Lee M, Deng J, Lee Y, You M, Liu J
Front Public Health. 2025; 12():1451318.
PMID: 39839410
PMC: 11746007.
DOI: 10.3389/fpubh.2024.1451318.
Gomes da Silva P, Goncalves J, Rodriguez E, Garcia-Encina P, Nascimento M, Sousa S
Food Environ Virol. 2024; 17(1):4.
PMID: 39614965
PMC: 11608306.
DOI: 10.1007/s12560-024-09615-1.
Dhiman N, Gyanpuri V, Kumar A, Joshi D
Ann Neurosci. 2024; :09727531241284359.
PMID: 39544650
PMC: 11559500.
DOI: 10.1177/09727531241284359.
Zhang K, Zhong X, Fan X, Yu D, Chen Z, Zhao C
Sci Rep. 2024; 14(1):18232.
PMID: 39107338
PMC: 11303783.
DOI: 10.1038/s41598-024-68162-8.
Ahmad S, Degiannis J, Borucki J, Pouwels S, Rawaf D, Lala A
J Acute Med. 2024; 14(2):51-60.
PMID: 38855048
PMC: 11153312.
DOI: 10.6705/j.jacme.202406_14(2).0001.
A comprehensive benchmark for COVID-19 predictive modeling using electronic health records in intensive care.
Gao J, Zhu Y, Wang W, Wang Z, Dong G, Tang W
Patterns (N Y). 2024; 5(4):100951.
PMID: 38645764
PMC: 11026964.
DOI: 10.1016/j.patter.2024.100951.
The Outcomes of Patients with Omicron Variant Infection who Undergo Elective Surgery: A Propensity-score-matched Case-control Study.
Xiong X, Li R, Yan H, Mao Q
Int J Med Sci. 2024; 21(5):817-825.
PMID: 38616997
PMC: 11008485.
DOI: 10.7150/ijms.90695.
Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2.
Yu P, Ran J, Yang R, Zhu H, Lu S, Wu Y
Front Immunol. 2024; 15:1374913.
PMID: 38510237
PMC: 10950932.
DOI: 10.3389/fimmu.2024.1374913.
Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant.
An K, Yang X, Luo M, Yan J, Xu P, Zhang H
Proteins. 2024; 92(6):705-719.
PMID: 38183172
PMC: 11059747.
DOI: 10.1002/prot.26663.
Deciphering the rule of antigen-antibody amino acid interaction.
Jiang M, Fang C, Ma Y
Front Immunol. 2023; 14:1269916.
PMID: 38111576
PMC: 10725943.
DOI: 10.3389/fimmu.2023.1269916.
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma.
Mitra A, Mukherjee U, Mazumder S, Madhira V, Bergquist T, Shao Y
Blood Cancer J. 2023; 13(1):180.
PMID: 38057320
PMC: 10700604.
DOI: 10.1038/s41408-023-00901-y.
Relationships between COVID-19 healthcare outcomes and county characteristics in the U.S. for Delta (B.1.617.2) and Omicron (B.1.1.529 and BA.1.1) variants.
Bruckhaus A, Zhang Y, Salehi S, Abedi A, Duncan D
Front Public Health. 2023; 11:1252668.
PMID: 38045980
PMC: 10693294.
DOI: 10.3389/fpubh.2023.1252668.
Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study.
Shimazu H, Wada D, Maruyama S, Inoue A, Kashihara M, Yoshihara T
BMC Infect Dis. 2023; 23(1):780.
PMID: 37946111
PMC: 10636837.
DOI: 10.1186/s12879-023-08797-6.
Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study.
Zoumpoulis G, Deligiorgi P, Lamprinos D, Georgakopoulos P, Oikonomou E, Siasos G
Vaccines (Basel). 2023; 11(9).
PMID: 37766156
PMC: 10534426.
DOI: 10.3390/vaccines11091480.
Characterization of mild or asymptomatic patient admitted with Omicron variant of COVID-19 infection in Tibetan mobile cabin hospital China, August-October 2022.
Shao F, Li B, Shang J, Liu W, Wang H, Liu Q
Front Public Health. 2023; 11:1174944.
PMID: 37621611
PMC: 10444987.
DOI: 10.3389/fpubh.2023.1174944.
Real-World Effectiveness of Nirmatrelvir/Ritonavir and Dexamethasone Among Hospitalized Patients with COVID-19: A Prospective Cohort Study.
Liu W, Song Q, Li F, Cao Y, Han Y, Wu J
Infect Drug Resist. 2023; 16:5223-5231.
PMID: 37589014
PMC: 10426452.
DOI: 10.2147/IDR.S419373.
A topic models analysis of the news coverage of the Omicron variant in the United Kingdom press.
Mayor E, Miani A
BMC Public Health. 2023; 23(1):1509.
PMID: 37559013
PMC: 10410915.
DOI: 10.1186/s12889-023-16444-7.
Modeling the dynamics of COVID-19 in the presence of Delta and Omicron variants with vaccination and non-pharmaceutical interventions.
Saha S, Saha A
Heliyon. 2023; 9(7):e17900.
PMID: 37539217
PMC: 10395305.
DOI: 10.1016/j.heliyon.2023.e17900.
A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicity.
Jancy S, Lupitha S, Chandrasekharan A, Varadarajan S, Nelson-Sathi S, Prasad R
Biol Proced Online. 2023; 25(1):22.
PMID: 37495994
PMC: 10373420.
DOI: 10.1186/s12575-023-00214-1.
Quantifying the effect of isolation and negative certification on COVID-19 transmission.
Takeshita J, Murakami M, Kamo M, Naito W, Yasutaka T, Imoto S
Sci Rep. 2023; 13(1):11264.
PMID: 37438418
PMC: 10338484.
DOI: 10.1038/s41598-023-37872-w.
